Fund: ISHNBIO
iShares Nasdaq Biotechnology ETF (dis) | |
US4642875565 | |
05-02-2001 | |
Equity | |
Equity Sectors - Health Care | |
BlackRock iShares | |
BlackRock Fund Advisors | |
USD | |
1,000 | |
5% |
1M | 3M | 6M | 9M | 1R | 3R p.a. | 5R p.a. | 7R p.a. | 10R p.a. | od vnizku p.a. | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Výkonnosť fondu | -8.45% | -7.93% | 5.37% | -4.88% | -6.13% | -6.37% | 3.57% | 3.75% | 5.35% | N/A | |
Priemerná výkonnosť (36 meraní) | -0.11% | -1.54% | 4.73% | 5.94% | 4.98% | ||||||
Volatilita od priemernej výkonnosti | 8.74% | 27.22% | 10.43% | 7.40% | 5.66% |
Long | Short | Net | |
---|---|---|---|
Stock | 99.52% | 99.52% | |
Bond | |||
Other | |||
Cash | 0.48% | 0.48% |
Aktíva | 76,400 mil. |
Počet akcíí | 217 |
Počet dlhopisov | 0 |
Priebež. popl. | |
z toho Mng. popl. | 0.45 |
Výk. prémia | |
Trans. popl. |
Dividenda | 0.504 |
Dividendový výnos | 0.40% |
Rozhodný dátum | 21-03-2024 |
Frekvencia výplaty | štvrťročne |
Giant | 0.00% |
Large | 35.73% |
Medium | 38.21% |
Small | 14.52% |
Micro | 8.69% |
P/E | 19.06% |
P/BV | 3.84% |
Healthcare | 99.52% |
Derivatives | 0.48 |
Výnos do splatnosti p.a. | |
Modifikovaná durácia |
United States | 90.28% |
Canada | 0.49% |
Latin America | |
United Kingdom | 1.11% |
Eurozone | 2.94% |
Europe - ex Euro | 3.26% |
Europe - Emerging | |
Africa | |
Middle East | |
Japan | |
Australasia | 0.02% |
Asia - Developed | 0.05% |
Asia - Emerging | 1.36% |
Emerging Market | 1.36% |
Developed Country | 98.16% |
Not Classified |
Spoločnosť | Subsektor | Váha | Spoločnosť | Subsektor | Váha |
---|---|---|---|---|---|
Amgen Inc | Healthcare | 8.38% | Gilead Sciences Inc | Healthcare | 8.18% |
Regeneron Pharmaceuticals Inc | Healthcare | 8.12% | Vertex Pharmaceuticals Inc | Healthcare | 8.1% |
IQVIA Holdings Inc | Healthcare | 4.41% | Moderna Inc | Healthcare | 3.57% |
Biogen Inc | Healthcare | 3.03% | Mettler-Toledo International Inc | Healthcare | 2.76% |
Illumina Inc | Healthcare | 2.1% | Waters Corp | Healthcare | 1.98% |